Catalyst Capital Advisors’s Altimmune ALT Stock Holding History

Catalyst Capital Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-217	Closed	-$92K	–	423
2014 Q2	$92K	Buy	217 +99	+84%	+$44.8K	0.02%	325
2014 Q1	$65K	Buy	+118	New	+$68.9K	0.01%	295

Other funds holding ALT

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Potomac Capital Management New York $115M AUM

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Catalyst Capital Advisors's ALT Position: Q3 2014 in Review

Catalyst Capital Advisors sold out of Altimmune (ALT) in Q3 2014, closing a stake of 217 shares — an estimated $92K sold.

Catalyst Capital Advisors first reported a position in ALT in Q1 2014 and held it in 2 quarters. The position peaked at $92K in Q2 2014. 37 funds tracked by Wall St. Rank hold ALT as of Q3 2014.

Catalyst Capital Advisors reported no remaining Altimmune position as of Q3 2014 after selling out during the quarter.
Catalyst Capital Advisors sold 217 Altimmune shares in Q3 2014, an estimated $92K.
Catalyst Capital Advisors first reported a position in Altimmune in Q1 2014 and held it in 2 quarters.
Catalyst Capital Advisors's Altimmune position peaked at $92K in Q2 2014.
37 funds tracked by Wall St. Rank held Altimmune as of Q3 2014.

Based on Catalyst Capital Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.